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Abstract 
Methoxsalen has been used for the treatment of psoriasis. In order to develop 
alternative formulations for the topical administration of methoxsalen, 
chitosan coated microemulsion were evaluated as delivery vehicle.  
Microemulsions were prepared using water, soyabean oil. Egg 
phosphatidylcholine, ethanol and coated with chitosan. They were 
characterized for shape and surface morphology, droplet size and size 
distribution, zeta potential, pH and viscosity. The ability of the system to 
deliver into the skin was evaluated using dialysis membrane and human 
cadaver skin. The in vitro permeation data showed that the novel system 
cumulative amount released was 18.75 % lesser than the microemulsion. 
These studies clearly show that methoxsalen loaded chitosan-coated 
microemulsion provides control release of methoxsalen with retention on the 
skin. Therefore may be appropriate vehicle for topical delivery of 
methoxsalen. 
  
Keywords: Microemulsions; Soyabean; Methoxsalen; Chitosan 
 
Introduction  
Microemulsions and other related colloidal system 
have received increased attention during the past few 
years. Formulations based on microemulsions have 
several interesting characteristics viz, enhanced drug 
solubilization, good stability, and ease of 
manufacturing [1].Although microemulsion can be 
used to deliver drugs via several routes; the system has 
been extensively studied as vehicle for topical 
administration [2]. Chitosan coated microemulsion are 
the novel carrier system. Generally emulsions of 
micron size are coated with chitosan. It is clear, milky 
thermodynamically stable mixture of oil, surfactant, 
and co- surfactant. This emulsion offers a significant 
advantage of increasing solubility of active agents for 
delivering active agent through skin. Advantages of 
this system are high biodegradability and low toxicity,  
 
 
reduction in the clearance rate, increase in contact time 
with skin, ease of manufacturing etc [3]. 
 In case of psoriasis, methoxsalen has been 
administered topically or systemically. Earliest topical 
formulation such as ointment, cream, and lotion 
produced a persistent hyperpigmentation [4]. Then it 
was replaced by oral therapy. But bioavailability of 
methoxsalen is highly variable because of its low water 
solubility and marked first pass effect. It also causes 
nausea, nervousness and mental depression after oral 
administration, [5] because of these short coming 
topical deliveries of methoxsalen by means of some 
topical formulation was attempted.  
The aim of the present study was to develop and 
evaluate a novel delivery system as chitosan coated 
emulsion for the topical administration of Methoxsalen.  
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The benefits are: Prolonged effect, avoid first pass 
metabolism, reduction in adverse effect, retention on 
the skin, large contact area of drug as microemulsion. 
 
Materials and methods 
Materials 
Methoxsalen was obtained from Inga Laboratories Pvt. 
Ltd, Mumbai, as a gift sample. Isopropyl myristate 
(IPM), oleic acid (OA), ethyl oleate (EO) and 
Soyabean oil were purchased from CDH Laboratory 
Pvt. Ltd Mumbai, Egg phosphatidylcholine, ethanol 
were purchased from SD Fine Chemical, Mumbai, 
Chitosan and dialysis membrane was purchased from 
HiMedia Laboratories Pvt. Ltd. Mumbai. Excised 
human cadaver skin from the abdomen was obtained 
from Chhattisgarh Institute of Medical Sciences, 
Bilaspur, India. Other chemicals used were of 
analytical grade. 
 
Method of preparation 
Construction of pseudo-ternary phase diagram 
In order to find out the range of existence 
microemulsion, pseudo-ternary phase diagrams were 
constructed using the water titration method at ambient 
temperature 250C. Three phase diagrams were prepared 
with the 1:1, 2:1 and 3:1 weight ratios respectively of 
egg phosphatidylcholine to ethanol. Here egg 
phosphatidylcholine and ethanol act as surfactant and 
cosolvent respectively.   For each phase diagram at 
specific surfactant/cosolvent weight ratio, the ratios of 
soyabean oil to the mixture of surfactant and cosolvent 
were varied as 1:9,  2:8,  3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1. 
The mixtures of oil, surfactant and cosolvent at above 
weight ratios were diluted with water dropwise, under 
moderate magnetic stirring. After being equilibrated, 
the mixtures were assessed visually and determined as 
being microemulsion, crude emulsions or gels [6].  
 
Preparation of microemulsion 
A series of microemulsion formulations were prepared 
using soyabean oil as the oil phase, egg 
phosphatidylcholine as a surfactant and ethanol as 
cosolvent. In all the formulations, the amount of 
methoxsalen was kept constant. Accurately weighed 
methoxsalen was placed in a beaker; oil, surfactant, and 
cosolvent were added. Then the components were 
mixed by gently stirring with magnetic stirrer and 
water was added drop-wise. The mixture was stored at 
room temperature until further use [3].  
 
Preparation of chitosan coated microemulsion  
Initially 2% aqueous solution of acetic acid was 
prepared, from which 0.25 ml of this solution was 
mixed with 2 mg of chitosan to obtain a homogenous 
mixture. Then the prepared microemulsion was added 
to equal amount of the chitosan mixture. The 
concentration of chitosan in the microemulsion was 
4mg/ ml [3].  
 
 
Figure1. Phase diagram showing surfactant co-
solvent in ratio (3:1) 
 
Characterization 
Surface morphology and shape 
Microstructure of the formulation was characterized by 
TEM. The formulation (5 micro liters) was diluted with 
water (1 ml) in a volumetric flask and sonicated for 5 
minutes. Then one drop of the solution was placed on a 
carbon coated copper grid. One drop of 1% 
phosphotungstic acid was added to it. The superfluous 
phosphotungstic acid on sample was wiped off by filter 
paper and air dried for a minute. Finally the shape and 
size of formulations were examined by transmission 
electron microscope [7].  
 
Droplet size and Size distribution 
Droplet sizes of microemulsion and chitosan-coated 
microemulsion were determined by using dynamic 
light scattering method using melvern zeta master 
(MAL, 500962, Malvern, UK). One ml of formulation 
was diluted to 10 ml in a test tube and gently mixed 
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using a glass rod. The resultant emulsion was then 
subjected for particle size analysis [8].  
 
Zeta potential 
Zeta potential of formulations was determined by using 
dynamic light scattering method. (MAL, 500962, 
Malvern, UK). One ml of formulation was diluted to 10 
ml in a test tube and gently mixed using a glass rod. 
The resultant emulsion was subjected for zeta potential 
analysis [7]. 
 
 
Figure 2. Transmission electron microscopy image 
of formulation E3 
 
Measurement of pH 
The pH values of the chitosan-coated microemulsion 
were measured at 250 C using digital pH-meter 
(Systronic digital pH meter 335, India). About 2.5 gm 
of the emulsion was dispersed in 25 ml of distilled 
water .the pH meter was first calibrated with a known 
pH solution. Then the pH of prepared formulations was 
determined [7]. 
 
 
 
Figure 3. Transmission electron microscopy image 
of formulation E3C 
Measurement of viscosity 
The viscosities of the chitosan-emulsion were 
measured at 250C using digital viscometer (Model DU-
II, Brookfield, USA) [7].  
 
 
 
Figure 4. Transmission electron microscopy image 
of formulation E2C 
 
In vitro permeation studies 
Selection of receptor solution used for permeation 
experiments is critical in case of topical application 
because they mimic the in vitro situation. Buffer 
solutions are the most commonly used media for 
lipophilic compounds. Dialysis membrane (average flat 
width- 29.31 mm, average diameter- 17.5mm, capacity 
factor- 2.41ml/cm) was used as an artificial membrane 
for preliminary in vitro studies because of simplicity, 
homogeneity and uniformity. This membrane was 
hydrated in PBS (pH 5.5) for 24 hours prior to use.  
 
 
 
 
Figure 5. Graphical representation of particle size 
Behera et al. International Journal of Drug Delivery 2 (2010) 159-167 
 
 162
The permeation studies were carried out using a 
modified Franz Diffusion cell. The effective 
permeation area of the diffusion cell and receptor cell 
volume was 2.545 cm2 and 15ml respectively. The 
temperature of receptor fluid was maintained at 
37±1oC.  
 
Table 1. Composition of different microemulsion 
formulation 
 
Component E1 E2 E3 E4 E5 
Methoxsalen (mg) 0.05 0.05 0.05 0.05 0.05 
Soyabean oil (%) 4 6 8 10 11 
Egg 
phosphatidylcholine 
(%) 
15 30 36 24 39 
Ethanol (%) 5 10 12 8 13 
Water (%) 72 53 44 52 27 
 
The receptor compartment contained PBS (pH5.5). 
Dialysis membrane was mounted between the donor 
and receptor compartment. 1 gm formulation of drug 
was applied to the upper side of membrane in donor 
compartment. Samples were withdrawn through the 
sampling port of the diffusion cell at predetermined 
intervals over 24 hours and analyzed 
spectrophotometrically [9].  
 
 
 
Figure 6. Graphical representation of Polydispersity 
index 
 
An equal volume of fresh PBS (pH 5.5) maintained at 
37±1oC was replaced into the receptor compartment 
after each sampling. Cartesian plots of cumulative 
amount of drug in receptor compartment versus time 
were plotted. Flux (Jss, µg/cm2/hr.) was calculated 
from the slope of the steady state portion of these 
graphs. 
 
Table 2. Particle size distribution and Polydispersity 
index 
Formulation 
code 
Particle 
size in nm 
Polydispersity 
Index 
E1 512 0.507 
E2 510 0.659 
E3 391 0.505 
E4 372 0.610 
E5 425 0.525 
E1C 512 0.502 
E2C 519 0.650 
E3C 395 0.500 
E4C 365 0.625 
E5C 420 0.610 
 
Ex vivo permeation studies through human cadaver 
skin 
The skin which was collected not more than 3 days after 
postmortem was stored at 40C in formalin. The skin was 
immersed in purified water at 600C for 2 minutes. Then 
it treated to remove hair and subdermal tissues [10]. 
 
Table 3. Zeta potential of the formulation 
 
Formulation 
code 
Zeta potential 
(mV) 
E1 -37.8 
E2 - 40.2 
E3 - 49.1 
E1C 19.4 
E2 C 20.4 
E3C 23.8 
 
The penetration studies were carried out by using 
Franz- type diffusion cells. The cell had a diffusion 
surface area of 2.545 cm2   and a volume of 15ml in the 
receptor compartment. 
 
Table 4. pH value and viscosity of chitosan-coated 
microemulsion 
Formulation 
code 
       pH Viscosity 
(Pa.S) 
        E1C       5.10         20.2     
        E2C       5.68        22.1 
        E3C       5.48        23.4 
        E4C       5.75        21.3 
        E5C       5.60       23.8  
 
Table 5. Data of cumulative amount release from chitosan-coated microemulsion and one microemulsion 
through dialysis membrane 
 
                                   Cumulative amount released(µg) Sample 
collection 
time (hr) E1C E2C E3C E4C E5C E3 
1 
2 
3 
4 
5 
6 
12 
18 
24 
4.00 
13.5 
20.8 
27.20 
55.50 
157.62 
170.30 
263.32 
281.52 
3.12 
7.25 
17.02 
26.50 
38.30 
123.96 
163.60 
  275.92 
287.67 
5.89 
   11.50 
    23.53 
28.90 
70.82 
160.64 
210.85 
284.81 
292.32 
5.64 
10.65 
20.53 
25.64 
37.86 
128.29 
189.43 
272.64 
283.94 
4.27 
9.24 
13.73 
24.17 
40.30 
    93.83 
134.42 
220.34 
253.76 
15.35 
19.43 
    24.42 
    34.43 
62.82 
184.96 
230.58 
332.45 
372.59 
 
Human skin was mounted horizontally with the stratum 
corneum side up; dividing the cell into two 
compartments i.e. the donor and the receptor 
compartments.  
 
Table 6. Data of % of drug release and flux through 
dialysis membrane 
Formulation 
code 
% Release 
in 24 hr 
Flux 
(µg/cm2/hr) 
E1C 51.18 5.42 
E2C 52.38 5.63 
E3C 53.09 6.45 
E4C 50.9 5.28 
E5C 50.8 5.17 
E3 67.63 8.12 
 
The dermal side of skin was immersed in PBS (pH 5.5) 
and the formulation was in contact with outer skin 
layer. The receptor was filled with pH 5.5 saline 
phosphate buffered solution. The receptor compartment 
was maintained at 37± 0.5oC using water bath with 
thermostatic plate of magnetic stirrer and stirred at 300 
rpm by Teflon coated magnetic bead fitted to a 
magnetic stirrer. Formulation (1gm) was applied in the 
donor compartment. Pseudo- sink conditions were 
maintained throughout the duration of the permeation 
experiments. The duration of experiments was 24 hour. 
At prefixed intervals 1 ml of the receptor phase was 
withdrawn and analyzed spectrophotometrically to 
determine the amount of permeated methoxsalen. The 
withdrawn volume was replaced with fresh medium and 
a correction for dilution was introduced. The chamber 
was kept protected from light. Cartesian plots of 
cumulative amount of drug present in receptor 
compartment versus time were plotted. Flux (JSS, 
mg/cm2/hr) was calculated from the slope of the steady 
state portion of these graphs [7].  
 
 
 
Figure 7. Graphical representation of zeta potential 
 
Skin deposition studies  
At the end of the permeation studies, the skin surface 
was washed five times with ethanol: PBS (pH 5.5) 1:1 
solution, then with water to remove excess drug from 
the surface. The skin was then cut into small pieces. 
The tissue was further homogenized with ethanol: 
buffer solution (pH 5.5) 1:1 and left for 6 hr. at room 
temperature. After shaking for 5 min and centrifugation 
for 5 min at 5000rpm, the drug concentration at 
supernatant was determined spectrophotometrically [1].  
 
Stability study 
Stress conditions normally applied for evaluating the 
stability of microemulsion includes aging, temperature 
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and centrifugation. The main parameters which are 
used to determine the stability is phase separation, 
viscosity and globule size distribution [11]. Selected 
formulations were kept at three different temperatures 
i.e. 40C, 250C, 450C and observed for phase separation 
and particle size for about 45 days. Formulations were 
also subjected to centrifugation at 3000, 5000, 10,000 
rpm for 15 minutes at room temperature and samples 
were withdrawn after a particular time interval and 
observed for phase separation and average particle size. 
 
 
 
Figure 8. Comparison of cumulative amount release 
from chitosan-coated microemulsion through 
dialysis membrane 
 
Results 
Pseudoternary phase diagram 
The phase diagrams are used to find out the 
microemulsion region. The studied systems were 
composed of soyabean oil, egg phosphatidylcholine, 
ethanol and water. The pseudoternary phase diagrams 
with various weight ratios of egg phosphatidylcholine 
and ethanol were prepared and the best result i.e. (3:1 
ratio) is shown the figure 1. The shaded regions in 
these figures represents the microemulsion formation 
regions. The microemulsion region was changed 
slightly in size with increasing ratio of egg 
phosphatidylcholine to ethanol. 
 
Preparation of microemulsion and chitosan coated-
microemulsion 
The compositions of selected formulations are shown 
in the table1, microemulsion were produced using these 
compositions and then the corresponding chitosan-
coated emulsion (E1C, E2C, E3C, E4C, and E5C) was 
prepared by mixing equal amount of aqueous chitosan 
solution (4mg/ ml) to the above microemulsion. 
 
Surface morphology and shape 
The surface characteristics of microemulsion and 
chitosan-coated microemulsion were performed on 
three formulations selected on the basis of particle size 
viz E3, E3C, E2C formulations using transmission 
electron microscopy (TEM; CM12 Philips, USA).  The 
TEM micrographs of these formulations are presented 
in Fig No 2, 3, and 4. 
 
Table 7. Data of cumulative amount release from 
chitosan-coated microemulsion and one 
microemulsion through human cadaver skin 
 
Cumulative amount released (µg) Sample collection 
time (hr) 
E3 E3C 
0.5 
1 
1.5 
2 
3 
4 
5 
6 
8 
12 
24 
16.32 
20.40 
25.50 
35.85 
73.82 
108.58 
235.25 
245.30 
290.32 
360.42 
412.35 
5.62 
16.32 
24.30 
30.34 
42.57 
76.90 
152.61 
170.78 
220.97 
300.81 
308.42 
 
 
Droplet size and Size distribution 
The selected formulations were subjected for analysis 
by Malvern Zeta master (MAL, 500962, Malvern, UK). 
The results are shown in table 2 and graphical 
representation in fig no. 5 and  6. 
   
Zeta potential 
Zeta potential of the selected formulations was 
determined by Malvern Zeta master (MAL, 500962, 
Malvern, UK). The results are shown in table no. 3 and 
graphically represented in fig no.7.   
 
Measurement of pH 
The pH values of the chitosan-coated microemulsion 
were measured at 250 C using digital pH-meter 
(Systronic digital pH meter 335, India.). The results 
obtained are given in the table no.4.  
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Measurement of viscosity 
 Viscosity of the formulation plays an important role 
because it affects the permeation rate and stability. 
Viscosities of selected formulations were measured by 
viscometer (Model DU-II, Brookfield, USA) and the 
results are given in the table no. 4. 
 
Table 8. Data of % Release in 24 hr and Flux from 
excised human skin 
 
 
In vitro permeation studies 
Drug permeation study was conducted through 
cellophane membrane with selected optimized 
formulations (E1C, E2C, E3C, E4C, and E5C) and one 
microemulsion (E3) was studied by using locally 
fabricated Franz diffusion cell. The cumulative amount 
of methoxsalen released from chitosan-coated 
microemulsion formulations through an artificial 
membrane at various sampling time are presented in 
table no.5 and figure no. 8. The comparison between 
one microemulsion and one chitosan-coated 
microemulsion is also given in figure no. 9.The %of 
drug release and fluxes are also given in the table no. 6. 
 
Table 9. Data of % of drug deposited after 24 hour 
 
Formulation 
code 
% of drug 
deposited after 
24 hour 
         E3 24.13 
         E3C 41.88 
 
Ex vivo permeation studies through human cadaver 
skin 
To actually mimic the in vivo skin permeation study the 
permeation studies were performed using excised 
human cadaver skin mounted on Franz diffusion cell. 
The optimized formulations E3 and E3C were utilized 
to predict release profile from chitosan-coated 
microemulsion through human cadaver skin. The 
results are shown in the table no.7, and graphical 
representations are shown in the fig no.10. The % of 
drug release and the flux are given in the table no. 8. 
 
Skin deposition studies  
The amount of drug deposited after 24 hour of the 
permeation study through human cadaver skin was 
determined and presented in the table no. 9. 
 
Stability study   
Selected formulations were kept at three different 
temperatures i.e. 40C, 250C, 450C.The formulations 
E1C. E2C, E4C and E5C shows phase separation at 45 
days. But the formulation E3C was found stable at all 
temperatures and for 45 days. The particle size of the 
formulation (E1C. E2C, E4C and E5C) also change at 
higher temperature. The formulation E1C, E2C, E3C 
shows no change in phase separation or particle size 
distribution after centrifugation and the formulation 
E4C, E5C show change in their particle size.  
 
 
 
Figure 9. Comparison of cumulative amount release 
from chitosan-coated microemulsion and 
microemulsion through dialysis membrane 
 
Discussion     
From the phase diagrams it was concluded that the area 
of microemulsion formed was greater in the surfactant, 
co-solvent ratio 3:1.So this ratio can be chosen for 
microemulsion preparation. 
TEM imaging of chitosan-coated microemulsion 
revealed that droplets were spherical in shape even 
after addition of chitosan. The result obtained from the 
DLS study (particle size) was also confirmed spherical 
shape of particles. 
The particle size of microemulsion and chitosan-coated 
microemulsion in table no. 2. Particle size of 
Formulation 
code 
% Release 
in 24 hr 
Flux (µg/cm2/hr) 
E3 74.87 6.25 
E3C 56.12 5.43 
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formulation E3 was smallest among other formulations. 
Polydispersity Index of this formulation was also lesser 
than other formulations. The particle size of chitosan-
coated microemulsion was also relatively constant as 
compared to their corresponding microemulsion. From 
this it is concluded that particle size does not vary 
considerably with coating by chitosan. (Nagamoto et 
al.2004) The Polydispersity Index of all the 
formulations is also comparable and does not vary 
significantly. This concludes that all the formulations 
possess uniform particle size droplets.  
Zeta potential of all the prepared microemulsions are 
greater than -30 mv so the formulations can be 
considered. Further the Zeta potential of chitosan-
coated microemulsion is positive. From this it is 
concluded that the emulsion is coated by chitosan.  
The pH value of the formulation E3C is 5.48 which is 
near the value of the skin, so it not produce any adverse 
effect or irritation on the skin. The viscosities of all 
formulations are nearly same and suitable for topical 
delivery. 
 
 
 
Figure 10. Graphical presentation of cumulative 
drug release across excised human skin 
 
In vitro release with dialysis membrane revealed that 
all formulations exhibit good in vitro release 
characteristics. The formulation E3C shows maximum 
flux. From the fig no 8 it is inferred that microemulsion 
E3C has higher permeation than the chitosan-coated 
microemulsion. Percentage of drug release is also 
higher for the formulation E3C. From the fig 9 it is 
concluded that chitosan-coated microemulsion are 
having control release than other microemulsions .The 
cumulative amount of drug release and the flux was 
found in the range of 50.8-53.09 % and 5.28-56.45 
µg/cm2/hr respectively. The cumulative amount of drug 
release was compared with the plain microemulsion 
and found that chitosan-coated microemulsion showed 
18.75% lesser release. Either no lag or small lag phase 
was observed with formulations. This suggests a quick 
onset. The permeation of methoxsalen through human 
cadaver skin was determined which mimic most in vivo 
condition for permeation of the drug. The amount of 
drug received in receptor compartment during 24 hr 
study period from formulations (100 mg) was 
determined with sampling at periodic intervals. From 
result represented graphically (fig no.10) it was seen 
that the formulations possess control release through 
skin. The transdermal flux calculated is low, exhibit 
that there is no or very small lag time to reach the 
receptor solution. The % release of methoxsalen 
through human cadaver skin in 24 hours from chitosan-
coated microemulsion is lower than the general 
microemulsion. The amount of drug deposited after 24 
hour is higher than the microemulsion. This result 
indicates it can be used for effective topical delivery. 
Stability studies were conducted for chitosan-coated 
microemulsion by storing the E3C formulation at 
refrigeration temperature (4oC) room temperature 
(25oC) and accelerated temperature (45oC) for 45 days. 
From the result it is concluded that formulation is 
stable at low and room temperature. The formulations 
were subjected for centrifugation study at 3000, 5000 
and 10000 rpm. The formulations showed no change in 
phase separation or particle size distribution. This 
suggested that formulations were stable and can be 
stored for longer period of time. 
These studies clearly show that methoxsalen loaded 
chitosan-coated microemulsion provide control release 
with retention on the skin. 
Additional advantage of chitosan-coated 
microemulsion is ease of application on skin. The 
formulation is easy to scale up as the procedure is 
simple and does not involve lengthy procedure and 
unnecessary use of pharmaceutically unacceptable 
additives. 
In conclusion, we can state that aim of project has been 
met viz., to circumvent the drawbacks of convention 
dosage form and retention on the skin. Thus chitosan-
coated microemulsion acts as a novel system for topical 
delivery of methoxsalen. 
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Conclusions 
These studies clearly show that methoxsalen loaded 
chitosan-coated micro emulsion provide control release 
with retention on the skin. Additional advantage of 
chitosan-coated micro emulsion is ease of application 
on skin. The formulation is easy to scale up as the 
procedure is simple and does not involve lengthy 
procedure and unnecessary use of pharmaceutically 
unacceptable additives. In conclusion, we can state that 
aim of project has been met viz., to circumvent the 
drawbacks of convention dosage form and retention on 
the skin. Thus chitosan-coated micro emulsion acts as a 
novel system for topical delivery of methoxsalen. 
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